Connect with us
TYMLOS® new patient adds in April: modest growth vs. previous 4-month trailing averages ~67% of new patients in April were initiated by a fracture focused bone...
NEW YORK, May 17, 2021 /PRNewswire/ — Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing...
CAMBRIDGE, Mass., May 13, 2021 /PRNewswire/ — Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today reported financial results...
Regulatory and policy developments during the first quarter of 2021 reflect a global tipping point toward serious regulation of artificial intelligence (“AI”) in the U.S. and...
Phase 2/3 clinical trial for Tempol for the prevention of hospitalizations in patients with COVID-19 expected to initiate in the second quarter of 2021 Management...
OSLO, Norway & NEW YORK–(BUSINESS WIRE)–Apr 8, 2021– FREYR AS, (the “Company” or “FREYR”), the Norway-based developer of clean, next-generation battery cell production capacity set...
NANTES, France–(BUSINESS WIRE)–Regulatory News: OSE Immunotherapeutics (Paris:OSE) (ISIN: FR0012127173; Mnemo: OSE) today reported its consolidated annual financial results for 2020 and provided an update on...
MINNEAPOLIS, March 26, 2021 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), is re-issuing this press release solely to correct an inadvertent decimal error in...
The Coronavirus Aid, Relief, and Economic Security Act (as amended and modified, the “CARES Act”) was enacted to provide immediate assistance to individuals, families, and...
– FPI-1434 Phase 1 study is progressing – Recent transactions and partnerships expand and diversify Fusion’s pipeline of targeted alpha therapies in development to treat a...
